Ciranova and TSMC Announce Strategic Partnership on Advanced PDK Technology
“Ciranova’s PyCell technology and advanced architecture provides native support of interoperable PDKs, which are an integral part of our Open Innovation Platform™, to facilitate and accelerate designers' innovations in analog and full custom designs,” said Fu-Chieh Hsu, vice president of Design & Technology Platform at TSMC. “We are collaborating with Ciranova to develop the industry’s first interoperable PDK, a single PDK that supports multiple design environments. We continue to work with Ciranova and the interoperable PDK Library (IPL) Alliance to accelerate the deployment and adoption of interoperable PDK across the industry.” “Every leading-edge SoC company in the world is under pressure to ramp more advanced design kits faster, despite limited time and resources,” said Eric Filseth, CEO of Ciranova. “TSMC is the foundry gold standard, and we’re excited to be working with them to push the state of the art of PDKs forward.”
About PyCells
Ciranova interoperable PyCells are a next-generation approach to parameterized cell development for custom IC design. Unlike older PCell approaches, the PyCell architecture is design-rule aware and generates DRC-correct device geometry automatically; the result is a major reduction in user coding effort, particularly at nanometer process nodes. PyCells run in any OpenAccess-capable EDA tool, and were selected as the physical foundation for the Interoperable PDK Alliance at http://www.iplnow.com. The PyCell Studio development system is a free download from http://www.ciranova.com.
About TSMC
TSMC is the world’s largest dedicated semiconductor foundry, providing the industry’s leading process technology and the foundry’s largest portfolio of process-proven libraries, IP, design tools and reference flows. The Company’s total managed capacity in 2008 exceeded 9 million (8-inch equivalent) wafers, including capacity from two advanced 12-inch - GIGAFABs ™, four eight-inch fabs, one six-inch fab, as well as TSMC’s wholly owned subsidiaries, WaferTech and TSMC (Shanghai), and its joint venture fab, SSMC. TSMC is the first foundry to provide 40nm production capabilities. Its corporate headquarters are in Hsinchu, Taiwan. For more information about TSMC please see http://www.tsmc.com.
About Ciranova
Ciranova is an electronic design automation (EDA) company focused on very large productivity improvements in analog, RF and mixed-signal IC physical design. Complementary to existing design flows, Ciranova technology dramatically reduces the time and effort needed to develop device-level layout at both the circuit and PDK levels, while delivering results of equal or better quality than purely handcrafted methods. Ciranova supports the Si2 OpenAccess database. For more information please visit http://www.ciranova.com.
|
Related News
- Synopsys and TSMC Usher In Angstrom-Scale Designs with Certified EDA Flows on Advanced TSMC A16 and N2P Processes
- Rapidus Announces Strategic Partnership with Quest Global to Enable Advanced 2nm Solutions for the AI Chip Era
- eMemory Won TSMC OIP Partner of the Year Award for the Outstanding Development of its NVM IP on Advanced Nodes
- M31 has successfully launched MIPI C/D PHY Combo IP on the advanced TSMC 5nm process
- Synopsys Accelerates Next-Level Chip Innovation on TSMC Advanced Processes
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |